Neurotrophin-3
An endogenous neurotrophic growth factor of the neurotrophin family that signals through the TrkC receptor to promote neuronal survival, differentiation, and synaptic plasticity, with therapeutic potential for neurodegenerative diseases and peripheral neuropathies.
Neurotrophin-3 (NT-3) is a neurotrophic factor that promotes the survival, growth, and differentiation of neurons and glial cells, particularly in the peripheral and central nervous systems. It binds to the TrkC receptor and plays critical roles in nerve regeneration, neuronal development, and synaptic function. NT-3 is primarily studied for therapeutic applications in nerve injury repair, spinal cord injury, and neurodegenerative conditions.
Overview
Neurotrophin-3 (NT-3) is a 119-amino-acid homodimeric protein belonging to the neurotrophin family of growth factors, which also includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-4/5 (NT-4/5). NT-3 signals primarily through its high-affinity receptor TrkC (tropomyosin receptor kinase C) and also binds the low-affinity p75NTR receptor shared by all neurotrophins. Among the neurotrophins, NT-3 has the broadest expression pattern during embryonic development and plays critical roles in the survival and differentiation of proprioceptive sensory neurons (dorsal root ganglia neurons that sense body position), sympathetic neurons, and specific populations of central neurons including cerebellar granule cells and hippocampal neurons. NT-3 is also the principal neurotrophin for the development and maintenance of muscle spindle afferents — the sensory neurons that provide feedback about muscle stretch and position.
The therapeutic potential of NT-3 has been explored across several neurological conditions. In peripheral neuropathy research, clinical trials have demonstrated that subcutaneous NT-3 administration (150 mcg/kg three times weekly) improves sensory nerve function in patients with Charcot-Marie-Tooth disease type 1A (CMT1A), a hereditary demyelinating neuropathy affecting approximately 1 in 2,500 people. Treated patients showed improvements in neuropathy impairment scores, sensory testing, and regenerating nerve fiber density. For spinal cord injury, preclinical studies have shown that NT-3 promotes axonal regeneration of corticospinal tract neurons — the primary motor pathway — and enhances functional recovery when combined with cellular scaffolds or gene therapy delivery systems. NT-3 also supports cochlear spiral ganglion neuron survival, making it a candidate for combination therapy with cochlear implants to improve auditory outcomes in sensorineural hearing loss.
NT-3 signals through TrkC receptor autophosphorylation, activating downstream cascades including the Ras-MAPK/ERK pathway (promoting neuronal survival and differentiation), the PI3K-Akt pathway (anti-apoptotic signaling), and the PLC-gamma pathway (synaptic plasticity modulation). A key challenge for therapeutic application is the short biological half-life and poor CNS penetration of recombinant NT-3 protein, which has driven development of gene therapy approaches, engineered delivery vehicles, and small-molecule TrkC agonists. NT-3 research intersects with other neurotrophic factor therapies including BDNF-based approaches and peptide-derived neurotrophic agents like Semax and cerebrolysin, which indirectly modulate neurotrophin signaling pathways. The compound remains investigational, with no approved therapeutic products, though its well-characterized role in neural development and repair continues to make it an active area of translational neuroscience research.
Mechanism of Action
Neurotrophin-3 (NT-3) is a member of the neurotrophin family that signals primarily through its high-affinity receptor TrkC (tropomyosin receptor kinase C), with lower affinity binding to TrkA, TrkB, and the p75NTR pan-neurotrophin receptor. Upon NT-3 binding, TrkC undergoes dimerization and autophosphorylation of intracellular tyrosine residues, activating three major downstream signaling cascades: the Ras/MAPK/ERK pathway promoting neuronal differentiation and survival, the PI3K/Akt pathway mediating anti-apoptotic signaling through phosphorylation and inactivation of pro-apoptotic proteins (Bad, Bax, caspase-9), and the PLC-gamma/IP3/DAG pathway regulating intracellular calcium release and PKC activation for synaptic plasticity.
NT-3 plays a critical role in neurogenesis, axonal growth, and synaptic formation during development and in the adult nervous system. It promotes survival and differentiation of proprioceptive sensory neurons in dorsal root ganglia, sympathetic neurons, and specific populations of CNS neurons including hippocampal and cortical neurons. NT-3 enhances myelination by promoting oligodendrocyte precursor cell proliferation and differentiation through TrkC signaling. Through p75NTR, the pro-form of NT-3 (proNT-3) can activate NF-kB survival signaling or, in the absence of Trk co-expression, trigger JNK-mediated apoptosis, creating a binary survival/death switch depending on receptor context.
Therapeutically, NT-3 is investigated for peripheral neuropathies (particularly chemotherapy-induced and diabetic neuropathy), spinal cord injury, and sensorineural hearing loss due to its ability to promote axonal regeneration and neuronal survival. It supports Schwann cell-mediated peripheral nerve remyelination and has shown efficacy in restoring proprioceptive function. Challenges include poor blood-brain barrier penetration and short half-life, driving development of sustained-release delivery systems and small-molecule TrkC agonists as alternatives.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Reported Effects
Dosage-Dependent Response:: Optimal effects observed at 50 ng/ml for cell proliferation, with lower doses (1-5 ng/ml) effective for neuroprotection. Enhanced Recovery:: Significantly improves locomotor function and morphological outcomes when used in spinal cord injury models. Synergistic Effects:: Works effectively in combination with other neurotrophic factors like BDNF and FGF2 for enhanced outcomes. Clinical Potential:: Shows promise for autologous transplant therapies using nasal ensheathing cells, though primarily in research settings
- Optimal effects observed at 50 ng/ml for cell proliferation, with lower doses (1-5 ng/ml) effective for neuroprotection
- Significantly improves locomotor function and morphological outcomes when used in spinal cord injury models
- Works effectively in combination with other neurotrophic factors like BDNF and FGF2 for enhanced outcomes
- Shows promise for autologous transplant therapies using nasal ensheathing cells, though primarily in research settings
Safety Profile
Neurotrophin-3 is an investigational biologic with limited human safety data. Potential side effects include injection site reactions, pain, and paresthesias. It should be avoided by individuals with active malignancies, as neurotrophins can promote tumor growth, and it is contraindicated during pregnancy and breastfeeding.
Pharmacokinetic Profile
Quick Start
- Typical Dose
- 1-5 ng/ml for neuroprotection studies and viral resistance in neuronal cultures
Safety Profile
Common Side Effects
- Limited Data:: Few side effects reported in research settings as NT-3 is not commonly used as a consumer supplement
- Specialized Application:: Most studies involve gene therapy or cell culture rather than direct supplementation, limiting side effect profiles
- Regulatory Status:: NT-3 is primarily a research compound and not approved for general supplementation use
- Unknown Long-term Effects:: Long-term safety data in humans for direct NT-3 administration is limited
References (8)
- [3]Combined application of brain-derived neurotrophic factor and neurotrophin-3 and its impact on spiral ganglion neuron firing properties
→ Combined BDNF and NT-3 treatment maintained resting membrane potentials and regulated firing threshold in cultured spiral ganglion neurons without altering firing adaptation.
- [8]Immunological isolation and characterization of neuronal progenitors from human dental pulp
→ Neurotrophin-3 was used as a neurotrophic factor supplement along with other factors to induce neuronal differentiation in PSA-NCAM+ cells isolated from dental pulp stem cells.
- [2]Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury
→ NT-3 gene-modified olfactory ensheathing cells survived in vivo and significantly improved recovery after spinal cord injury by promoting axon regeneration and locomotor function.
- [4]Nerve growth factor and neurotrophin-3 modulate the rabies infection of adult sensory neurons in primary cultures
→ NT-3 at 1-5 ng/ml significantly reduced rabies virus infection in adult sensory neurons while not affecting non-neuronal cell infection rates.
- [5]Site-specific interactions of neurotrophin-3 and fibroblast growth factor in the embryonic development of the mouse cochlear nucleus
→ NT-3 and its receptor TrkC are present during neural precursor migration and morphogenesis, tracking migration routes and developmental sequences in the cochlear nucleus.
- [6]Differential effects of NGF and NT-3 on embryonic trigeminal axon growth patterns
→ NT-3 promotes precocious development of short axon collaterals with focal arbors along the central trigeminal tract, affecting both central and peripheral axon growth patterns.
- [7]The effects of 12 weeks resistance training and vitamin D administration on neuromuscular joint, muscle strength and power in postmenopausal women
→ The study examined NT-3 concentrations as a potential biomarker alongside CAF in postmenopausal women undergoing resistance training and vitamin D supplementation for neuromuscular health.
- [1]Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose
→ NT-3 at 50 ng/ml optimally promotes purification and proliferation of nasal ensheathing glial cells, which show potential for nerve repair in clinical applications using autologous transplants.